Suppr超能文献

药物或药物联合认知行为治疗难治性双相障碍患者的良好结局预测因素。

Predictors of good outcome in patients with refractory bipolar disorder after a drug or a drug and cognitive-behavioral treatment.

机构信息

Servicio de Psiquiatría, Complejo Hospitalario Universitario Materno-Infantil de Gran Canaria, Las Palmas, Spain.

出版信息

Compr Psychiatry. 2012 Apr;53(3):224-9. doi: 10.1016/j.comppsych.2011.05.001. Epub 2011 Jun 12.

Abstract

OBJECTIVE

The objective of the present research study was to analyze the variables involved in the favorable prognosis of patients with refractory bipolar disorder after a drug or a drug and cognitive-behavioral treatment.

METHODS

A sample of 40 patients was divided into 2 groups: (1) combined drug plus psychoeducational and cognitive-behavioral treatment or (2) drug treatment only (control group). We used a multigroup design with repeated measures at different times (baseline, posttreatment, 6-month follow-up, and 12-month follow-up) to evaluate the following variables: age, sex, number of hospitalizations, type of treatment, mania (Young Mania Rating Scale, or YMRS) and depression (Beck Depression Index, or BDI) symptoms, subsyndromal symptoms (BDI >7; YMRS >6), global suffering index, general index of social ability, self-esteem (Rosenberg scale), inadaptation (inadaptation Scale), anxiety (State-Trait Anxiety Inventory), quality of life (Global Activity Functioning), and health (European Quality of Life Scale). We considered favorable prognosis for subjects without persistent affective symptoms (BDI <7; YMRS <6) and/or without relevant difficulties in adaptation (Inadaptation Scale <14) in a 12-month follow-up.

RESULTS

A binary logistic regression showed that the type of treatment (combined therapy corresponded to better progression), the number of prior hospitalizations (fewer hospitalizations corresponded to better progression), and self-esteem (higher self-esteem corresponded to better prognosis) were statistically significant.

CONCLUSIONS

The type of treatment, the number of prior hospitalizations, and the level of self-esteem were the most influencing factors for a favorable progression of refractory bipolar disorder. Differently from other studies, no significant influences of age, sex, subsyndromal symptoms, anxiety, and depression symptoms on the prognosis of refractory bipolar disorder were observed in our study.

摘要

目的

本研究旨在分析药物或药物联合认知行为治疗后难治性双相障碍患者预后良好的相关变量。

方法

40 名患者分为两组:(1)联合药物加心理教育和认知行为治疗,或(2)仅药物治疗(对照组)。我们采用多组设计,在不同时间(基线、治疗后、6 个月随访和 12 个月随访)进行重复测量,评估以下变量:年龄、性别、住院次数、治疗类型、躁狂(Young Mania Rating Scale,YMRS)和抑郁(Beck Depression Index,BDI)症状、亚综合征症状(BDI>7;YMRS>6)、总体痛苦指数、一般社会能力指数、自尊(Rosenberg 量表)、不适应(不适应量表)、焦虑(状态-特质焦虑量表)、生活质量(全球活动功能)和健康(欧洲生活质量量表)。我们认为在 12 个月随访时无持续性情感症状(BDI<7;YMRS<6)和/或无相关适应困难(不适应量表<14)的患者预后良好。

结果

二项逻辑回归显示,治疗类型(联合治疗与更好的进展相关)、既往住院次数(住院次数越少,进展越好)和自尊(自尊越高,预后越好)具有统计学意义。

结论

治疗类型、既往住院次数和自尊水平是难治性双相障碍预后良好的最主要影响因素。与其他研究不同,在本研究中,我们未观察到年龄、性别、亚综合征症状、焦虑和抑郁症状对难治性双相障碍预后有显著影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验